Yutaka Furutani

Lecturer

Jikei University School of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yutaka Furutani is a Lecturer at Jikei University School of Medicine in Japan. His research areas include the regulation of liver diseases, predictive biomarkers in hepatocellular carcinoma, and antiviral mechanisms, as demonstrated in his recent publications. He has contributed significantly to studies on nonalcoholic fatty liver disease, hepatitis B virus, and the role of epigenetics in viral infections.

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Kento Yonezawa

Project Assitant Professor

Nara Institute of Science and Technology

JAPAN

View details

Sae Ochi

Professor

Jikei University School of Medicine

JAPAN

View details

Pornparn Kongpracha

University of California, San Francisco

UNITED STATES

View details

Yoshinori Hirano

Keio University

JAPAN

View details

Shushi Nagamori

Jikei University School of Medicine

JAPAN

View details

Nobutaka Shimizu

Professor

High Energy Accelerator Research Organization

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yutaka Furutani

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Corn Oligopeptide Alleviates Nonalcoholic Fatty Liver Disease by Regulating the Sirtuin Signaling Pathway.

Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence.

Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid

A small molecule iCDM-34 identified by in silico screening suppresses HBV DNA through activation of aryl hydrocarbon receptor

Determination of a Serum 25-Hydroxyvitamin D Reference Ranges in Japanese Adults Using Fully Automated Liquid Chromatography-Tandem Mass Spectrometry.

SEB genotyping: SmartAmp-Eprimer binary code genotyping for complex, highly variable targets applied to HBV.

Establishment of a Rapid Detection System for ISG20-Dependent SARS-CoV-2 Subreplicon RNA Degradation Induced by Interferon-α

Latency-associated Peptide Degradation Fragments Produced in Stellate Cells and Phagocytosed by Macrophages in Bile Duct-ligated Mouse Liver.

Design, synthesis, and target identification of new hypoxia-inducible factor 1 (HIF-1) inhibitors containing 1-alkyl-1H-pyrazole-3-carboxamide moiety

Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells.

Inhibition of Ganglioside Synthesis Suppressed Liver Cancer Cell Proliferation through Targeting Kinetochore Metaphase Signaling.

Transglutaminase 2 as a Marker for Inflammation and Therapeutic Target in Sepsis.

MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.

Collaborators (6)

Kento Yonezawa

Sae Ochi

Pornparn Kongpracha

Yoshinori Hirano

Shushi Nagamori

Nobutaka Shimizu

Make your next move.